KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) EPS (Basic): 2009-2024

Historic EPS (Basic) for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -$1.45.

  • Teva Pharmaceutical Industries' EPS (Basic) rose 197.44% to $0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.63, marking a year-over-year increase of 174.12%. This contributed to the annual value of -$1.45 for FY2024, which is 190.00% down from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' EPS (Basic) is -$1.45, which was down 190.00% from -$0.50 recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' EPS (Basic) registered a high of $0.38 during FY2021, and its lowest value of -$3.64 during FY2020.
  • Over the past 3 years, Teva Pharmaceutical Industries' median EPS (Basic) value was -$1.45 (recorded in 2024), while the average stood at -$1.38.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' EPS (Basic) skyrocketed by 110.44% in 2021 and then tumbled by 678.95% in 2022.
  • Teva Pharmaceutical Industries' EPS (Basic) (Yearly) stood at -$3.64 in 2020, then soared by 110.44% to $0.38 in 2021, then slumped by 678.95% to -$2.20 in 2022, then spiked by 77.27% to -$0.50 in 2023, then plummeted by 190.00% to -$1.45 in 2024.